Study of a new drug for relapsed or refractory non-Hodgkin's lymphoma
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests an experimental drug, SP-3164, for people with certain types of non-Hodgkin's lymphoma that have come back or not responded to prior treatments. The goal is to see if the drug can help shrink or control the cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of B-cell non-Hodgkin's lymphoma (like diffuse large B-cell lymphoma, mantle cell lymphoma, follicular lymphoma, or marginal zone lymphoma) that has returned or not responded to treatment.
- You have had at least 2 prior lines of systemic therapy (like chemotherapy or targeted drugs) for your lymphoma.
- You have measurable disease (at least one tumor that can be seen on scans).
- You are able to perform daily activities (ECOG performance status 0 or 1).
- You have a tissue sample from a previous biopsy (or are willing to have a new biopsy) for testing.
- Your organ and bone marrow function are within normal limits as per lab tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug, SAR448501/DR-0201, for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. The goal is to see if the drug is safe and can shrink tumors.
This early-phase trial tests an experimental drug called STR-P004 in people with certain types of B-cell lymphoma that have come back or not responded to standard treatments. The goal is to check the drug's safety and see if it helps shrink or control the lymphoma.
This study tests an experimental drug (GSK5926371) for people with a type of lymphoma (B-cell NHL) that has come back or not responded to earlier treatments. The goal is to see if the drug is safe and if it can help shrink or control the cancer.
This study tests an experimental drug for people with B-cell non-Hodgkin lymphoma (a type of blood cancer) that has come back or hasn't responded to standard treatments. The goal is to see if the drug is safe and can shrink the cancer.
This trial tests a new drug, BMS-986458, alone or with other lymphoma treatments, for people with non-Hodgkin lymphoma that has come back or not gotten better after prior treatment.
This trial tests an experimental drug (HSK47977) to see how it works in people with non-Hodgkin lymphoma that has come back or not responded to treatment. The goal is to understand how the drug is processed by the body, its safety, and whether it can help shrink tumors.
Hear when a new Lymphoma, Non-Hodgkin's, Adult trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.